BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8444058)

  • 1. Contributions of post-antibiotic lag and repair-recovery to the post-antibiotic effects of ciprofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1993; 39(1):22-31. PubMed ID: 8444058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-antibiotic effects of ofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pyogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1993; 39(4):265-71. PubMed ID: 8325128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-antibiotic effects of cefdinir on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyrogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1994; 40(4):232-8. PubMed ID: 8082410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
    Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
    Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo postantibiotic effect in a thigh infection in neutropenic mice.
    Vogelman B; Gudmundsson S; Turnidge J; Leggett J; Craig WA
    J Infect Dis; 1988 Feb; 157(2):287-98. PubMed ID: 3121761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postantibiotic effects of eleven antimicrobials on five bacteria.
    Wang MG; Zhang YY; Zhu DM; Zhang J; Shi YG
    Acta Pharmacol Sin; 2001 Sep; 22(9):804-8. PubMed ID: 11749860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
    Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
    Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.
    Lagast H; Husson M; Klastersky J
    J Antimicrob Chemother; 1985 Sep; 16(3):341-7. PubMed ID: 2932416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.
    Fuursted K
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1693-6. PubMed ID: 9257743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro postantibiotic effect of roxithromycin and erythromycin against gram-positive cocci.
    Chang JC; Hsueh PR; Young C
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):276-84. PubMed ID: 1342645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of lung bacterial clearance in normal mice.
    Jay SJ; Johanson WG; Pierce AK; Reisch JS
    J Clin Invest; 1976 Apr; 57(4):811-7. PubMed ID: 7575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution and changes in the susceptibility of bacteria isolated from clinical samples. II].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jun; 38(6):1587-602. PubMed ID: 3900459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the antimicrobial effect of vitamin D (author's transl)].
    Feindt E; Ströder J
    Klin Wochenschr; 1977 May; 55(10):507-8. PubMed ID: 195120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens.
    Landini G; Di Maggio T; Sergio F; Docquier JD; Rossolini GM; Pallecchi L
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7513-7517. PubMed ID: 27736757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of subinhibitory concentrations of moxifloxacin in an in-vitro dynamic model.
    Maggiolo F; Capra R; Bartoli A; Bottura P; Migliorino M; Suter F
    J Chemother; 2000 Apr; 12(2):129-33. PubMed ID: 10789551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    So W; Crandon JL; Nicolau DP
    J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a microplate method for determining the post-antibiotic effect in Staphylococcus aureus and Escherichia coli.
    Stubbings WJ; Bostock JM; Ingham E; Chopra I
    J Antimicrob Chemother; 2004 Jul; 54(1):139-43. PubMed ID: 15150167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.